• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by SeqLL Inc.

    11/14/23 4:30:25 PM ET
    $SQL
    Medical Specialities
    Health Care
    Get the next $SQL alert in real time by email
    NT 10-Q 1 ea188273-nt10q_seqllinc.htm NOTIFICATION OF LATE FILING

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

    NOTIFICATION OF LATE FILING

     

      (Check One):   ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐  Form 10-D ☐ Form N-SAR ☐ Form N-CSR
           
          For Period Ended: September 30, 2023
           
          ☐   Transition Report on Form 10-K
          ☐   Transition Report on Form 20-F
          ☐   Transition Report on Form 11-K
          ☐   Transition Report on Form 10-Q
          ☐   Transition Report on Form N-SAR
           
          For the Transition Period Ended:                               

     

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    PART I — REGISTRANT INFORMATION

     

     

     

    SeqLL Inc.
    Full Name of Registrant
     
    N/A
    Former Name if Applicable
     

    3 Federal Street

    Address of Principal Executive Office (Street and Number)
     
    Billerica, MA 01821
    City, State and Zip Code

     

     

     

     

    PART II — RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

        (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
         

     

    ☒

      (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
         
        (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III — NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q,10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    SeqLL Inc. (the “Registrant”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023 (the “Form 10-Q”). The compilation, dissemination and review of the information required to be presented in the Form 10-Q for the relevant period, including, without limitation, the financial statements to be included therein, has imposed time constraints that have rendered timely filing of the Form 10-Q impracticable without undue hardship and expense to the Registrant. The Registrant undertakes the responsibility to file, and anticipates that it will file, the Form 10-Q no later than five days after its original prescribed due date.

     

    PART IV — OTHER INFORMATION

     

    (1)Name and telephone number of person to contact in regard to this notification

     

     

    Daniel Jones, Chief Executive Officer

      (781)   460-6016
    (Name)   (Area Code)   (Telephone Number)

       

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).
      ☒ Yes ☐ No
       

     

    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
      ☐ Yes ☒ No
       
       
    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    2

     

     

    SeqLL Inc.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: November 14, 2023 By:

    /s/ Daniel Jones

       

    Daniel Jones

       

    Chief Executive Officer

     

     

    3

     

     

    Get the next $SQL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SQL

    DatePrice TargetRatingAnalyst
    2/9/2022$3.00Buy
    Maxim Group
    More analyst ratings

    $SQL
    SEC Filings

    View All

    SEC Form EFFECT filed by SeqLL Inc.

    EFFECT - SeqLL, Inc. (0001605888) (Filer)

    2/13/24 12:15:19 AM ET
    $SQL
    Medical Specialities
    Health Care

    SEC Form S-1/A filed by SeqLL Inc. (Amendment)

    S-1/A - SeqLL, Inc. (0001605888) (Filer)

    2/12/24 3:01:45 PM ET
    $SQL
    Medical Specialities
    Health Care

    SEC Form S-1/A filed by SeqLL Inc. (Amendment)

    S-1/A - SeqLL, Inc. (0001605888) (Filer)

    2/9/24 5:23:38 PM ET
    $SQL
    Medical Specialities
    Health Care

    $SQL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on SeqLL with a new price target

    Maxim Group initiated coverage of SeqLL with a rating of Buy and set a new price target of $3.00

    2/9/22 8:40:22 AM ET
    $SQL
    Medical Specialities
    Health Care

    $SQL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Pfeffer David bought $20,163 worth of shares (20,000 units at $1.01), increasing direct ownership by 22% to 20,000 units (Amendment)

    4/A - SeqLL, Inc. (0001605888) (Issuer)

    1/30/23 11:37:35 AM ET
    $SQL
    Medical Specialities
    Health Care

    SEC Form 4: Milos Patrice M. bought $10,088 worth of shares (10,000 units at $1.01), increasing direct ownership by 14% to 10,000 units (Amendment)

    4/A - SeqLL, Inc. (0001605888) (Issuer)

    1/30/23 11:37:03 AM ET
    $SQL
    Medical Specialities
    Health Care

    SEC Form 4: Jones Daniel Robert bought $2,236 worth of shares (5,733 units at $0.39), increasing direct ownership by 0.24% to 2,392,365 units (Amendment)

    4/A - SeqLL, Inc. (0001605888) (Issuer)

    1/30/23 11:36:38 AM ET
    $SQL
    Medical Specialities
    Health Care

    $SQL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Atlantic International Corp. Acquires Lyneer Staffing Solutions

    ENGLEWOOD CLIFFS, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Atlantic International Corp. (OTC:ATLN) (OTC:SEQL) today announced the acquisition ("Acquisition") of Lyneer Staffing Solutions ("Lyneer"), a 28 year old national strategic staffing outsourced services and workforce solutions company servicing the commercial, professional, finance, direct placement, and managed service provider verticals. Lyneer has over 1,100 customers, including, among others, enterprise scale customers UPS, DHL, FedEx, XPO Logistics, Ryder, Ikea, PepsiCo, T-Mobile, Kraft Heinz, and Red Bull. The Company is using its best efforts to uplist in the near future onto a National Securities Exchange and remains optimist

    6/21/24 7:00:00 AM ET
    $SQL
    Medical Specialities
    Health Care

    SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition

    BILLERICA, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), today announced the decision of its Board of Directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of Lyneer Investments LLC ("Lyneer") and the disposition of its current business operations. The Company had previously set September 26, 2023 as the record date for the dividends (the "Record Date"). While the Record Date had been set, the dividends had not yet been declared by the Board nor had the amount of the proposed dividends been set

    10/30/23 4:30:00 PM ET
    $SQL
    Medical Specialities
    Health Care

    SeqLL Announces Cash and Stock Dividend Record Date

    BILLERICA, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), announced today that its board of directors has set September 26, 2023 as the record date for its special stock dividend and cash dividend to be made to the holders of its common stock pursuant to the terms of the Agreement and Plan of Reorganization dated as of May 29, 2023, as amended (the "Merger Agreement"), by and among the Company, SeqLL Merger LLC, Atlantic Acquisition Corp., Atlantic Merger LLC, Lyneer Investments, LLC, IDC Technologies, Inc. and Lyneer Management Holdings LLC. The dividend distribution of shares of common stock of the Company and the cash dividend will

    9/15/23 5:24:58 PM ET
    $SQL
    Medical Specialities
    Health Care

    $SQL
    Financials

    Live finance-specific insights

    View All

    Atlantic International Corp. Acquires Lyneer Staffing Solutions

    ENGLEWOOD CLIFFS, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Atlantic International Corp. (OTC:ATLN) (OTC:SEQL) today announced the acquisition ("Acquisition") of Lyneer Staffing Solutions ("Lyneer"), a 28 year old national strategic staffing outsourced services and workforce solutions company servicing the commercial, professional, finance, direct placement, and managed service provider verticals. Lyneer has over 1,100 customers, including, among others, enterprise scale customers UPS, DHL, FedEx, XPO Logistics, Ryder, Ikea, PepsiCo, T-Mobile, Kraft Heinz, and Red Bull. The Company is using its best efforts to uplist in the near future onto a National Securities Exchange and remains optimist

    6/21/24 7:00:00 AM ET
    $SQL
    Medical Specialities
    Health Care

    SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition

    BILLERICA, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), today announced the decision of its Board of Directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of Lyneer Investments LLC ("Lyneer") and the disposition of its current business operations. The Company had previously set September 26, 2023 as the record date for the dividends (the "Record Date"). While the Record Date had been set, the dividends had not yet been declared by the Board nor had the amount of the proposed dividends been set

    10/30/23 4:30:00 PM ET
    $SQL
    Medical Specialities
    Health Care

    SeqLL Inc. Enters into a Definitive Merger Agreement with Lyneer Staffing Solutions and Atlantic Acquisition Corp.

    BILLERICA, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), a technology company providing life sciences instrumentation and research services, today announced that it has entered into a definitive merger agreement (the "Merger Agreement") with Lyneer Investments, LLC ("Lyneer"), the indirect parent company of Lyneer Staffing Solutions, LLC and Atlantic Acquisition Corp. ("Atlantic"), and related parties, pursuant to which Lyneer will become a wholly-owned subsidiary of SeqLL. Under the terms of the Merger Agreement, SeqLL will pay $60,000,000 in cash to the Lyneer members, and issue to the Lyneer members and Atlantic, an aggregate o

    5/30/23 8:30:00 AM ET
    $SQL
    Medical Specialities
    Health Care